"A groundbreaking trial has commenced in the UK and US to test a new bird flu vaccine for humans, with thousands of participants expected to enrol. The study particularly encourages poultry farmers and individuals with close contact with birds to sign up, aiming to proactively address the growing threat posed by the A(H5N1) strain."
"Experts warn that while the virus is 'evolving and spreading' rapidly among animals, and does not yet easily transmit between people, the potential for human-to-human transmission must be treated 'as a real possibility'."
"The vaccine, mRNA-1018, developed by Moderna, utilises mRNA technology similar to that employed in Covid-19 jabs. This innovative approach instructs the body to produce specific viral proteins, thereby training the immune system to swiftly recognise and combat the illness should exposure occur."
A new bird flu vaccine trial, mRNA-1018, has started in the UK and US, aiming to address the A(H5N1) strain threat. Thousands of participants, especially poultry farmers, are encouraged to enroll. Experts emphasize the potential for human-to-human transmission, making this trial crucial for pandemic preparedness. The vaccine uses mRNA technology similar to Covid-19 vaccines, training the immune system to recognize and combat the virus. The phase 3 trial will involve around 4,000 individuals, with a significant portion being over 65 years old in the UK.
Read at www.independent.co.uk
Unable to calculate read time
Collection
[
|
...
]